Sire Bioscience Inc. (CNSX:SIRE) signed an Letter of Intent to acquire Fusion Nutrition Inc. for $0.7 million on November 14, 2019. As part of the transaction, the consideration for the issuance of common shares of SIRE at a price per share price equal to the closing price of SIRE's shares on the trading day immediately prior to the closing of the acquisition, but in any event no less than $0.05 per share, for an aggregate transaction value of between $0.4 million to $0.7 million. Sire Bioscience Inc. (CNSX:SIRE) entered into a definitive agreement to acquire Fusion Nutrition Inc. for $0.15 million on May 3, 2020.

Sire Bioscience will acquire Fusion Nutrition Incorporated in exchange for $145,682 worth of common shares of the Sire Bioscience at a value of $0.05 per common share, subject to any approvals required by the Canadian Securities Exchange. Adrian Burke, a Director of Sire Bioscience purchased or acquired direction and control over a total of $32,389.5 worth of the Consideration Shares in the Transaction.